Virtu Financial LLC Marker Therapeutics, Inc. Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.3 - $3.73 $1,049 - $13,047	3,498 Added 21.19%	20,004 $7,000
Q2 2022 Aug 09, 2022	BUY	$0.26 - $0.46 $4,291 - $7,592	16,506 New	16,506 $5,000
Q1 2022 May 17, 2022	SELL	$0.37 - $1.0 $4,822 - $13,034	-13,034 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$0.95 - $1.72 $30,689 - $55,564	-32,305 Reduced 71.25%	13,034 $12,000
Q3 2021 Nov 12, 2021	BUY	$1.68 - $2.88 $76,169 - $130,576	45,339 New	45,339 $77,000
Q1 2021 May 19, 2021	SELL	$1.47 - $3.29 $112,047 - $250,773	-76,223 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.36 - $1.75 $46,234 - $59,493	33,996 Added 80.51%	76,223 $111,000
Q3 2020 Dec 11, 2020	BUY	$1.5 - $2.2 $44,862 - $65,797	29,908 Added 242.78%	42,227 $63,000
Q2 2020 Aug 07, 2020	SELL	$1.69 - $2.79 $30,871 - $50,964	-18,267 Reduced 59.72%	12,319 $26,000
Q4 2019 Feb 04, 2020	BUY	$2.68 - $4.85 $18,492 - $33,465	6,900 Added 29.13%	30,586 $88,000
Q3 2019 Nov 20, 2019	BUY	$4.1 - $9.0 $97,112 - $213,174	23,686 New	23,686 $121,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $259M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.